Fenofibrate clinical trials
Also written Tricor and Triglide.
How each study uses Fenofibrate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Fenofibrate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 31 Dec 1993 · TRICOR (MICRONIZED) · NDA 019304 (FDA, Drugs@FDA)
- European Union
- 14 Apr 2011 · Pravafenix · EMEA/H/C/001243 (EMA; in a combination)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
130 studies that test it; most in 2005 (15)
| Year | Studies |
|---|---|
| 2001 | 2 |
| 2002 | 5 |
| 2003 | 8 |
| 2004 | 5 |
| 2005 | 15 |
| 2006 | 7 |
| 2007 | 4 |
| 2008 | 7 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 5 |
| 2014 | 7 |
| 2015 | 2 |
| 2016 | 8 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 6 |
| 2023 | 8 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 41 · Other 92
Solvay Pharmaceuticals (14) · Xijing Hospital of Digestive Diseases (9) · Tanta University (5) · Ranbaxy Laboratories Limited (4) · Sanofi (3) · Gachon University Gil Medical Center (3) · Pfizer (3) · The University of Texas Medical Branch, Galveston (3)
Often tested with
Tested in the same studies.
Simvastatin (9) · Niacin (9) · Atorvastatin (8) · Metformin (7) · Ezetimibe (6) · Rosuvastatin (5) · Pravastatin (4) · Omega-3 fatty acid (4)
Related medicines
As reviewed, each with the page that says it.
- One of Hypolipidemic Agents source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 3, 1 in phase 3
Studies that test Fenofibrate, phase 3 first.
- Apr 2027Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)Phase 2/3 · Xijing Hospital of Digestive Diseases
- Apr 2027Clinical Study Evaluating the Efficacy and Safety of Fenofibrates Versus Silymarin in Adult Patients With SepsisPhase 2 · Tanta University
- Oct 2027Comparison Of Fenofibrate Vs Phenobarbitone As Adjunct To Phototherapy In Reducing Total Serum Bilirubin In Indirect Hyperbilirubinemia In NeonatesPhase 4 · Rubab Fatima
Studies
Open first, then newest update. How each study uses Fenofibrate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 133
- FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC TherapyRecruitingPhase 3Xijing Hospital of Digestive DiseasesNCT07296458Written as Fenofibrate
- Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic AcidRecruitingPhase 3Xijing Hospital of Digestive DiseasesNCT02823366Written as Fenofibrate
- Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)RecruitingPhase 2/3Xijing Hospital of Digestive DiseasesNCT06365424Written as Fenofibrate
- Comparison Of Fenofibrate Vs Phenobarbitone As Adjunct To Phototherapy In Reducing Total Serum Bilirubin In Indirect Hyperbilirubinemia In NeonatesNot yet recruitingPhase 4Rubab FatimaNCT07774741Written as Fenofibrate + Phototherapy
- Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver TransplantationRecruitingPhase 2Mayo ClinicNCT06905054Written as Fenofibrate (drug)
- Clinical Study Evaluating the Efficacy and Safety of Fenofibrates Versus Silymarin in Adult Patients With SepsisNot yet recruitingPhase 2Tanta UniversityNCT07572552Written as Fenofibrate
- Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary CholangitisRecruitingPhase 3Xijing Hospital of Digestive DiseasesNCT05751967Written as Fenofibrate Combined With Ursodeoxycholic Acid
- Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World StudyRecruitingPhase 3Xijing Hospital of Digestive DiseasesNCT06755541Written as Fenofibrate in Combination With Ursodeoxycholic Acid
- Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary CholangitisRecruitingPhase 2/3Xijing Hospital of Digestive DiseasesNCT05749822Written as Fenofibrate 200mg
- Fenofibrate in Primary Biliary Cholangitis: a Real World StudyRecruitingPhase 3Xijing Hospital of Digestive DiseasesNCT06755151Written as Fenofibrate
- Fenofibrate Role in the Prophylaxis From Peripheral Neuropathy Induced by Bortezomib, Lenalidomide and Dexamethasone (VRd) Protocol in the Treatment of Patients With Multiple Myeloma (MM)RecruitingPhase 4Tanta UniversityNCT07025005Written as Bortezomib + Lenalidomide + Dexamethasone + Fenofibrate 160 mg tablet
- Comparison of Effects of Fenofibrate Adjuvant Therapy Versus Conventional Phototherapy in Neonatal Jaundice.Not yet recruitingPhase 2/3Muhammad ZarkNCT06346743Written as Fenofibrate
- Prolonged Remission Induced by Phenofibrate in Children Newly Diagnosed With Type 1 Diabetes.RecruitingPhase 2Medical University of WarsawNCT05909800Written as Phenofibrate
- A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 DiabetesCompletedPhase 2Alessandro DoriaNCT04929379Written as Fenofibrate
- Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary CholangitisActive, not recruitingPhase 2/3Han YingNCT06174402Written as Fenofibrate
- Repurposing Fenofibrate in Modulating AMPK/NLRP3 Inflammasome in Patients With Ulcerative ColitisCompletedPhase 2Tanta UniversityNCT05781698Written as Fenofibrate
- Serine and Fenofibrate Study in Patients With MacTel Type 2CompletedPhase 2The Lowy Medical Research Institute LimitedNCT04907084Written as Fenofibrate
- A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary CholangitisCompletedEarly Phase 1Han YingNCT06591455Written as Fenofibrate
- Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)Active, not recruitingEarly Phase 1Xijing Hospital of Digestive DiseasesNCT07104201Written as Fenofibrate
- Fenofibrate for Prevention of DR WorseningActive, not recruitingPhase 3Jaeb Center for Health ResearchNCT04661358Written as Fenofibrate
See all 133 studies that test Fenofibrate →
Given beside what is tested · 9 — Fenofibrate is usual care or a partner of the new treatment
- Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical CarcinomaRecruitingPhase 1Lindsay Ferguson, MDNCT06191133Written as Fenofibrate
- Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal FunctionCompletedPhase 3Kowa Research Institute, Inc.NCT03001817Written as Fenofibrate
- Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal ImpairmentCompletedPhase 3Kowa Research Institute, Inc.NCT03011450Written as Fenofibrate
- A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe HypertriglyceridemiaCompletedPhase 2Novartis PharmaceuticalsNCT01594983Written as Fenofibrate
- Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With HypercholesterolemiaCompletedPhase 4SanofiNCT02984982Written as Fenofibrate
- Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRSCompletedPhase 2Aegerion Pharmaceuticals, Inc.NCT00559962Written as AEGR-733 and fenofibrate
- Effect of Alirocumab (SAR236553/REGN727) Administered on Top of Ezetimibe or Fenofibrate on Lipid Profiles in Healthy SubjectsCompletedPhase 1SanofiNCT01723735Written as Fenofibrate
- Effects of PPAR Ligands on Ectopic Fat Accumulation and InflammationCompletedNot applicableVA Office of Research and DevelopmentNCT00470262Written as Fenofibrate 145mg PO QD
- Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol LevelsCompletedPhase 2TakedaNCT00813527Written as Lapaquistat acetate and fenofibrate
As the comparator · 10 — what is tested is compared with Fenofibrate
- A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-CCompletedPhase 3Kowa Company, Ltd.NCT04998981Written as Fenofibrate 200 mg capsule
- Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in DyslipidemiaCompletedPhase 2Veloxis PharmaceuticalsNCT00504829Written as fenofibrate
- A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects.CompletedPhase 2AstraZenecaNCT02354976Written as Fenofibrate 200mg
- Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)CompletedPhase 4SanofiNCT02642159Written as Fenofibrate
- A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined HyperlipidemiaCompletedPhase 3ShionogiNCT00459745Written as Fenofibrate
- MK0767 in Metabolic Syndrome-Dyslipidemia (0767-016)TerminatedPhase 2Merck Sharp & Dohme LLCNCT00703690Written as Comparator: fenofibrate
- A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular DiseaseCompletedPhase 3AbbottNCT01674712Written as Fenofibrate 145 mg
- A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With DyslipidemiaCompletedPhase 2Zydus Lifesciences LimitedNCT01539616Written as Fenofibrate
- Comparison of Coenzyme A and Fenofibrate for Safety and Efficacy On Patients With HyperlipidemiaCompletedPhase 3Zhejiang UniversityNCT01878227Written as Fenofibrate 200mg
- Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol LevelsCompletedPhase 2TakedaNCT00813527Written as Lapaquistat acetate and fenofibrate
What changed recently
From the registry's own updates since Oct 20, 2026.
Started recruiting1
Results posted1
- A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 DiabetesNov 10, 2026NCT04929379
Codes
What other systems call Fenofibrate · ClinicalTrials.gg INT008095
- MeSH (NLM) D011345FenofibrateConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) U202363UOSFENOFIBRATEConfirmed FDA, NLM, Wikidata
- Wikidata Q419724fenofibrateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C29047FenofibrateConfirmed FDA, Wikidata
- DrugBank DB01039One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D011345 | Fenofibrate | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | U202363UOS | FENOFIBRATE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q419724 | fenofibrate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C29047 | Fenofibrate | Confirmed FDA, Wikidata |
| DrugBank | DB01039 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.